Entry Detail



General Information

Database ID:TRD00140
Confidence:Median
Contents:>> tsRNA Information
>> tsRNA Association Statistics
>> Disease Information
>> Disease Association Statistics
>> Evidence Support
>> Reference



tsRNA Information

tsRNA Name:tsrna-13349
tsRNA Type:5'-tiRNA
Amino acid and Anticodon:GluTTC
Sequence:TCCCATATGGTCTAGCGGTTAGGATTCCTGGTTTT
Related Target:N/A
Predicted Target:CYB561A3//SGMS2//MOB3C//PPP1R26//KMT2B//COL4A3//WSCD2//SRGAP2C//CCDC24//GTF3C4
External Links:
MINTbase ID:tRF-35-86V8WPMN1E8Y7Z
tRFdb ID:N/A

[1] gtRNAdb_ID:tRNA-Glu-TTC-1-2
Anticodon:GluTTC
tRNA_number:trna5
Chromosome:13
Strand:-
Coordinate:Start Site(bp): 41634911        End Site(bp): 41634945

[2] gtRNAdb_ID:tRNA-Glu-TTC-1-1
Anticodon:GluTTC
tRNA_number:trna20
Chromosome:2
Strand:-
Coordinate:Start Site(bp): 131094738        End Site(bp): 131094772



tsRNA Association Statistics

Total Associated Disease Number:3
More Information
Network:
(Display the first 15 nodes)



Disease Information

 MeSHDisease Ontology
Disease ID:D021441DOID:3498
Disease Name:Carcinoma, Pancreatic Ductalpancreatic ductal adenocarcinoma
Category:MeSHDisease Ontology
Type:Neoplasms//Digestive System Diseases//Endocrine System Diseasesdisease of anatomical entity//disease of cellular proliferation
Define:Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.A pancreatic adenocarcinoma that derives_from pancreatic duct cells.
Alias:Carcinoma, Ductal, Pancreatic//Duct-Cell Carcinoma of the Pancreas//Duct-Cell Carcinoma, Pancreas//Ductal Carcinoma of the Pancreas//Pancreatic Duct Cell Carcinoma//Pancreatic Ductal Carcinomaductal adenocarcinoma of the pancreas



Disease Association Statistics

Total Associated tsRNA Number:114
More Information
Network:
(Display the first 15 nodes)



Evidence Support

Strong Evidence:N/A
Weak Evidence:High-throughput sequencing



Reference

[1] PubMed ID:33791157
Disease Name:Carcinoma, Pancreatic Ductal
Tissue:Serum
Dysfunction Pattern:Up-Regulation
Validated Method:High-throughput sequencing
Description:There were 45 tsRNAs expressed at remarkably higher levels, 14 tsRNAs expressed at lower levels in PDAC patients, respectively, compared with healthy volunteers.
Comparision:Cancer VS Normal
Mechanism:N/A